Health
Cellid, IVI sign research service contract to evaluate immunogenicity of COVID-19 vaccine – News-Medical.Net
Cellid and the International Vaccine Institute have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine “AdCLD-CoV19″….
Cellid and the International Vaccine Institute (IVI) have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine “AdCLD-CoV19”.
Cellid and IVI announced on January 4 that they have signed a research service contract to cooperate in the clinical development of the “AdCLD-CoV19”, a COVID-19 vaccine being developed by Cellid.
Under this contract, IVI will analyze samples from Phase 1/2a clinical trials of Cellid’s COVID-19 vaccine “AdCLD-CoV19” to determine…
-
General16 hours agoFerries and celebrities as pollies dash to win the west
-
Noosa News21 hours agoCSIRO, winemakers pair to breed mildew, climate-resistant grapevines
-
Noosa News17 hours agoChild killer Rick Thorburn who murdered Tiahleigh Palmer found dead in jail cell
-
Business21 hours ago3 ASX 200 stocks I’d buy and hold for the next 10 years